Prosecution Insights
Prosecution Insights
Listed by the USPTO as WILLIS, DOUGLAS M
Tech Center 1600 • Art Units: 1624 1691
This examiner grants 82% of resolved cases
Douglas M. Willis is an examiner in Tech Center 1600 and Art Unit 1624, with 1812 resolved cases. His allowance rate is 82.3 percent. This combination of 1812 cases and the 82.3 percent grant rate provides a statistical profile for practitioners. The allowance rate suggests that a majority of applications he reviews will eventually be granted.
The interview lift for his cases is 19.7 percent. While the base rate is 82.3 percent, interviews still provide a boost to the chances of success. Additionally, the median days to allowance is 687. Applicants can expect a resolution and a likelihood of a grant when their cases are handled by this examiner. The 687 median days, combined with the 82.3 percent allowance rate, defines the prosecution experience in Art Unit 1624. Practitioners can use the resolved cases to predict future outcomes based on this specific volume of data.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18458292 | THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 18739860 | PI4KIIIBETA INHIBITORS | Non-Final OA | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
| 18665390 | HETEROCYCLIC NLRP3 INHIBITORS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18710813 | GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18694848 | COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT | Non-Final OA | MIRATI THERAPEUTICS, INC. |
| 18258812 | METHACRYLAMIDES PROTEIN BINDERS AND USES THEREOF | Non-Final OA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy82.3% of resolved applications examined by Douglas M Willis were allowed (1,817 resolved cases), compared with 54.6% across Art Unit 1624 over the last five years.
This examiner's interview lift is +19.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Douglas M Willis took 688 days on average from filing to allowance.
Douglas M Willis examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).